Hologic has a very good collaboration with public health and the open access functionality of the platform can allow for rapid development of new tests when necessary. Vendors can develop assays quickly but getting them thru FDA is neither fast nor cheap.

Yes, an issue here, but with our TGA. These companies make a lot of money on their successful kits-I'm not crying over them having to spend to do a relatively small amount of validation and the paperwork associated. The fact that reg bodies are slow is also an issue to be resolved.